Literature DB >> 28577764

Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance.

Nina Saxena1, John M Inadomi2.   

Abstract

Guidelines for the screening and surveillance of Barrett's esophagus continue to evolve as the incidence of esophageal adenocarcinoma increases, identification of individuals at highest risk for cancer improves, and management of dysplasia evolves. This article reviews related studies and economic analyses. Advances in diagnosis offer promising strategies to help focus screening efforts on those individuals who are most likely to develop esophageal adenocarcinoma. Published by Elsevier Inc.

Entities:  

Keywords:  Barrett’s esophagus; Cost-effectiveness; Endoscopy; Esophageal adenocarcinoma; Mass screening; Surveillance

Mesh：

Year:  2017        PMID： 28577764     DOI： 10.1016/j.giec.2017.02.005

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN： 1052-5157


  10 in total

1.  Evaluation of Dysplasia in Barrett Esophagus.

Authors:  Seth A Gross; Joseph Kingsbery; Janice Jang; Michelle Lee; Abraham Khan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-04

Review 2.  Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?

Authors:  John M Inadomi; Nina Saxena
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

3.  External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.

Authors:  Theresa H Nguyen; Aaron P Thrift; Gyanprakash A Ketwaroo; Xianglin L Du; Luis Leon Novelo; Rollin George; Daniel G Rosen; Hashem B El-Serag
Journal:  Gastrointest Endosc       Date:  2022-01-06       Impact factor: 10.396

Review 4.  Endoscopic surveillance or ablation for Barrett's esophagus?

Authors:  John M Inadomi; Nina Saxena
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-06

5.  Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.

Authors:  Tariq A Hammad; Aaron P Thrift; Hashem B El-Serag; Nisreen S Husain
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

Review 6.  Towards screening Barrett's oesophagus: current guidelines, imaging modalities and future developments.

Authors:  Ishaan Maitra; Ravindra Sudhachandra Date; Francis Luke Martin
Journal:  Clin J Gastroenterol       Date:  2020-06-03

7.  Esophageal cancer: Epidemiology, risk factors and screening.

Authors:  Jiang Li; Jianguo Xu; Yadi Zheng; Ya Gao; Siyi He; He Li; Kaiyong Zou; Ni Li; Jinhui Tian; Wanqing Chen; Jie He
Journal:  Chin J Cancer Res       Date:  2021-10-31       Impact factor: 4.026

8.  A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus.

Authors:  Jing Hao; Rebecca Critchley-Thorne; David L Diehl; Susan R Snyder
Journal:  Clinicoecon Outcomes Res       Date:  2019-10-25

Review 9.  Recent advances in understanding and preventing oesophageal cancer.

Authors:  James Franklin; Janusz Jankowski
Journal:  F1000Res       Date:  2020-04-21

10.  Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis.

Authors:  Nicola F Frei; Kadère Konte; Emily A Bossart; Katelyn Stebbins; Yi Zhang; Roos E Pouw; Rebecca J Critchley-Thorne; Jacques J G H M Bergman
Journal:  Clin Transl Gastroenterol       Date:  2020-10       Impact factor: 4.396
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.